Antibody-Drug Conjugates in Bladder Cancer.

Publication Year: 2018

DOI:
10.3233/BLC-180169

PMCID:
PMC6087439

PMID:
30112436

Journal Information

Full Title: Bladder Cancer

Abbreviation: Bladder Cancer

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Urology & Nephrology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
1/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"CONFLICT OF INTEREST STT has served as a paid consultant to Immunomedics. Weill Cornell Medicine has received funding for clinical trials from Immunomedics, Seattle Genetics, Genentech, Janssen, Astellas. The patent for J591 is assigned to the Cornell Center for Technology Licensing."

Funding Disclosure
Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025